Go Equity

The Austrian private equity house fell some way short of its original E100m target for its latest fund investing in Austrian SMEs.

VC firms back second-round financing for French multi-access firm; Go Equity leads E4m investment

Global Equity Partners and Go Equity also participated in the round.

The Austrian vaccine developer has landed the largest biotechnology financing round for two years with lead investments from MPM Capital and Global Life Science Ventures.

Boasting one of the largest institutional venture capital fund portfolios in Europe, the European Investment Fund is having to permanently balance commercial investment considerations with its political mandate. Not an easy task, finds Ricky Morton.

Austrian vaccine developer Intercell has completed one of the largest European venture capital funding rounds of 2003, with Apax, Nomura and NIB Capital among the investors.

Gamma Capital Partners plans to raise E25m for a high-tech VC fund focussed on Austria and its neighbouring countries, following a E10m first close.

Austrian debutant fundraiser Lead Equities has surpassed its original E40m target for a later-stage industrial private equity fund.

The Austrian private equity house has raised E40m at the first close of its fund targeting later-stage opportunities in Central and Eastern Europe.

Nuova Holdings, a fund targeting the less industrialised region of Southern Italy, has raised E100m for investments in small and medium size enterprises in the Mezzogiorno.